Sector: Health Care
Director information for CLOVER HEALTH INVESTMENTS CORP CLA (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Andrew Toy | Co-Founder, Chief Executive Officer and Director | 47 | [] | [] | 2026 |
| Anna U. Loengard, M.D. | Director | 57 | [] | ["Nominating and Corporate Governance Committee","Clinical Committee"] | 2026 |
| Carladenise Armbrister Edwards Ph.D | Director | 56 | [] | ["Talent and Compensation Committee","Nominating and Corporate Governance Committee","Audit Committee","Clinical Committee"] | 2026 |
| Demetrios L. Kouzoukas | Lead Independent Director | 50 | [] | ["Nominating and Corporate Governance Committee","Audit Committee","Clinical Committee"] | 2026 |
| Peter Kuipers | Chief Financial Officer | [] | [] | 2026 | |
| Thomas L. Tran | Director | 69 | [] | ["Nominating and Corporate Governance Committee","Audit Committee"] | 2026 |
| Vivek Garipalli | Co-Founder and Executive Chairperson | 47 | [] | [] | 2026 |
| William G. Robinson, Jr. | Director | 61 | [] | ["Talent and Compensation Committee","Audit Committee"] | 2026 |
